StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
HealthEquity (HQY) Reiterated at Market Outperform by Citizens: Q2 Revenue Above Estimate
August 28, 2026 4:40 AM
Citizens analyst Constantine Davides reiterated a Market Outperform rating and $111.00 price target on HealthEquity, Inc (NASDAQ: HQY).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments